United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,163,500 | 961,200 | 966,800 | 795,200 | 813,300 |
| Marketable Securities | 1,699,900 | 1,877,500 | 1,648,800 | 1,460,000 | 1,454,400 |
| Receivables | 134,500 | 220,400 | 231,700 | 173,400 | 170,500 |
| Inventories | 102,500 | 102,000 | 91,000 | 89,900 | 88,200 |
| Other current assets | 92,600 | 219,200 | 118,100 | 165,800 | 60,200 |
| TOTAL | $3,193,000 | $3,380,300 | $3,056,400 | $2,684,300 | $2,586,600 |
| Non-Current Assets | |||||
| PPE Net | 896,500 | 861,500 | 840,800 | 791,400 | 784,400 |
| Investments And Advances | 1,765,600 | 1,316,200 | 1,443,800 | 1,641,900 | 1,559,100 |
| Other Non-Current Assets | 490,900 | 486,500 | 440,600 | 425,700 | 429,700 |
| TOTAL | $3,153,000 | $2,664,200 | $2,725,200 | $2,859,000 | $2,773,200 |
| Total Assets | $6,346,000 | $6,044,500 | $5,781,600 | $5,543,300 | $5,359,800 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 239,700 | 229,900 | 220,100 | 196,600 | 166,400 |
| Other current liabilities | 84,900 | 113,300 | 95,800 | 134,900 | 126,200 |
| TOTAL | $324,600 | $343,200 | $315,900 | $331,500 | $292,600 |
| Non-Current Liabilities | |||||
| Long Term Debt | 800,000 | 800,000 | 800,000 | 800,000 | 800,000 |
| Other Non-Current Liabilities | 98,200 | 104,600 | 103,500 | 93,400 | 90,900 |
| TOTAL | $898,200 | $904,600 | $903,500 | $893,400 | $890,900 |
| Total Liabilities | $1,222,800 | $1,247,800 | $1,219,400 | $1,224,900 | $1,183,500 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,847 | 46,302 | 45,577 | 45,516 | 45,300 |
| Common Shares | 700 | 700 | 700 | 700 | 700 |
| Retained earnings | 5,283,200 | 5,042,300 | 4,910,200 | 4,670,900 | 4,554,900 |
| Other shareholders' equity | -39,000 | -55,700 | -84,300 | -65,700 | -54,500 |
| TOTAL | $5,123,200 | $4,796,700 | $4,562,200 | $4,318,400 | $4,176,300 |
| Total Liabilities And Equity | $6,346,000 | $6,044,500 | $5,781,600 | $5,543,300 | $5,359,800 |